July 10, 2026 Sophia Vida
Breaking News

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Advances progress towards planned Nasdaq uplisting PR Audio: POMPANO BEACH, Fla., July 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the filing … Continue reading “BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission”